keyword
Keywords Evaluation of no evidence of d...

Evaluation of no evidence of disease activity in a 7 year

https://read.qxmd.com/read/38621400/-177-lu-lu-psma-617-plus-enzalutamide-in-patients-with-metastatic-castration-resistant-prostate-cancer-enza-p-an-open-label-multicentre-randomised-phase-2-trial
#1
JOURNAL ARTICLE
Louise Emmett, Shalini Subramaniam, Megan Crumbaker, Andrew Nguyen, Anthony M Joshua, Andrew Weickhardt, Sze-Ting Lee, Siobhan Ng, Roslyn J Francis, Jeffrey C Goh, David A Pattison, Thean Hsiang Tan, Ian D Kirkwood, Craig Gedye, Natalie K Rutherford, Shahneen Sandhu, Aravind Ravi Kumar, David Pook, Shakher Ramdave, David P Nadebaum, Mark Voskoboynik, Andrew D Redfern, William Macdonald, Laurence Krieger, Geoff Schembri, Wei Chua, Peter Lin, Lisa Horvath, Patricia Bastick, Patrick Butler, Alison Yan Zhang, Sonia Yip, Hayley Thomas, Ailsa Langford, Michael S Hofman, Margaret McJannett, Andrew James Martin, Martin R Stockler, Ian D Davis
BACKGROUND: Enzalutamide and lutetium-177 [177 Lu]Lu-prostate-specific membrane antigen (PSMA)-617 both improve overall survival in patients with metastatic castration-resistant prostate cancer. Androgen and PSMA receptors have a close intracellular relationship, with data suggesting complementary benefit if targeted concurrently. In this study, we assessed the activity and safety of enzalutamide plus adaptive-dosed [177 Lu]Lu-PSMA-617 versus enzalutamide alone as first-line treatment for metastatic castration-resistant prostate cancer...
April 12, 2024: Lancet Oncology
https://read.qxmd.com/read/38578610/safety-and-preliminary-efficacy-of-pembrolizumab-following-trans-arterial-chemoembolization-for-hepatocellular-carcinoma-the-petal-phase-ib-study
#2
JOURNAL ARTICLE
David J Pinato, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Alexandra Emilia Schlaak, Ciro Celsa, Saskia Killmer, Jesus Miguens Blanco, Caroline Ward, Charalampos-Vlasios Stikas, Mark R Openshaw, Nicole Acuti, Georgios Nteliopoulos, Cristina Balcells, Hector C Keun, Robert D Goldin, Paul J Ross, Alessio Cortellini, Robert Thomas, Anna Mary Young, Nathan Danckert, Paul Tait, Julian R Marchesi, Bertram Bengsch, Rohini Sharma
BACKGROUND: TACE may prime adaptive immunity and enhance immunotherapy efficacy. PETAL evaluated safety, preliminary activity of TACE plus pembrolizumab and explored mechanisms of efficacy. METHODS: Patients with liver-confined HCC were planned to receive up to 2 rounds of TACE followed by pembrolizumab 200 mg every 21 days commencing 30-days post-TACE until disease progression or unacceptable toxicity for up to 1 year. Primary endpoint was safety, 21-days dose-limiting toxicities (DLT) from pembrolizumab initiation...
April 5, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38563436/effect-of-a-home-base-core-stability-exercises-in-hereditary-ataxia-a-randomized-controlled-trial-a-pilot-randomized-controlled-trial
#3
JOURNAL ARTICLE
Rosa Cabanas-Valdés, Helena Fernández-Lago, Selma Peláez-Hervás, Laura Serra-Rusiñol, Carlos López-de-Celis, Maria Masbernat-Almenara
BACKGROUND: Core stability exercises (CSE) have been shown to be effective in improving trunk function in several neurological diseases, but the evidence is scarce on Hereditary Ataxias (HA). OBJECTIVE: To evaluate the effectiveness of a 5-week home-based CSE program in terms of ataxia severity, trunk function, balance confidence, gait speed, lower limb motor function, quality of life, health status and falls rate in HA individuals at short- and long-term. METHODS: This is an assessor-blind randomized controlled clinical trial parallel group 1:1...
April 2, 2024: Movement Disorders Clinical Practice
https://read.qxmd.com/read/38513374/ten-year-outcomes-after-non-fixation-of-the-smaller-posterior-malleolar-fragment-a-retrospective-cohort-study
#4
JOURNAL ARTICLE
Leo Swee Liang Chong, MohammadAli Khademi, Kundam Murali Reddy, Geoffrey Hunter Anderson
INTRODUCTION: Treatment of posterior malleolar (PM) ankle fractures remains controversial. Despite increasing recommendation for small PM fragment fixation, high quality evidence demonstrating improved clinical outcomes over the unfixated PM is limited. We describe the long term clinical and radiographical outcomes in younger adult patients with PM ankle fractures managed without PM fragment fixation. MATERIAL AND METHODS: A retrospective cohort study was performed on PM ankle fracture patients aged 18-55 years old admitted under our orthopaedic unit between 1st of April 2009 and 31st of October 2013...
March 12, 2024: Foot
https://read.qxmd.com/read/38418770/real-world-retrospective-analysis-of-alemtuzumab-outcomes-in-relapsing-remitting-multiple-sclerosis-the-lemcam-study
#5
JOURNAL ARTICLE
Lucienne Costa-Frossard França, Virginia Meca Lallana, Andrés Labiano-Fontcuberta, Rosario Blasco, Enric Monreal, María Luisa Martínez Ginés, Clara Aguirre, Julia Sabin Muñoz, Susana Sainz de la Maza, Juan Pablo Cuello, Carolina Díaz-Pérez, Juan Luis Chico García, Alberto Lozano Ros, Fernando Rodríguez Jorge, Susana Martínez Martínez, José Manuel García Domínguez
BACKGROUND: Alemtuzumab is a high-efficacy treatment approved for relapsing-remitting multiple sclerosis (RRMS). Although clinical trials and observational studies are consistent in showing its efficacy and manageable safety profile, further studies under clinical practice conditions are needed to further support its clinical use. OBJECTIVE: The aim of this observational retrospective study was to evaluate the effectiveness and safety of alemtuzumab to add to the current real-world evidence on the drug...
February 28, 2024: CNS Drugs
https://read.qxmd.com/read/38402895/a-biomarker-stratified-comparison-of-top-down-versus-accelerated-step-up-treatment-strategies-for-patients-with-newly-diagnosed-crohn-s-disease-profile-a-multicentre-open-label-randomised-controlled-trial
#6
JOURNAL ARTICLE
Nurulamin M Noor, James C Lee, Simon Bond, Francis Dowling, Biljana Brezina, Kamal V Patel, Tariq Ahmad, Paul J Banim, James W Berrill, Rachel Cooney, Juan De La Revilla Negro, Shanika de Silva, Shahida Din, Dharmaraj Durai, John N Gordon, Peter M Irving, Matthew Johnson, Alexandra J Kent, Klaartje B Kok, Gordon W Moran, Craig Mowat, Pritash Patel, Chris S Probert, Tim Raine, Rebecca Saich, Abigail Seward, Dan Sharpstone, Melissa A Smith, Sreedhar Subramanian, Sara S Upponi, Alan Wiles, Horace R T Williams, Gijs R van den Brink, Séverine Vermeire, Vipul Jairath, Geert R D'Haens, Eoin F McKinney, Paul A Lyons, James O Lindsay, Nicholas A Kennedy, Kenneth G C Smith, Miles Parkes
BACKGROUND: Management strategies and clinical outcomes vary substantially in patients newly diagnosed with Crohn's disease. We evaluated the use of a putative prognostic biomarker to guide therapy by assessing outcomes in patients randomised to either top-down (ie, early combined immunosuppression with infliximab and immunomodulator) or accelerated step-up (conventional) treatment strategies. METHODS: PROFILE (PRedicting Outcomes For Crohn's disease using a moLecular biomarker) was a multicentre, open-label, biomarker-stratified, randomised controlled trial that enrolled adults with newly diagnosed active Crohn's disease (Harvey-Bradshaw Index ≥7, either elevated C-reactive protein or faecal calprotectin or both, and endoscopic evidence of active inflammation)...
February 21, 2024: Lancet. Gastroenterology & Hepatology
https://read.qxmd.com/read/38380456/an-unusual-etiology-of-fluorodeoxyglucose-avid-intrathoracic-lymph-nodes
#7
JOURNAL ARTICLE
Alyssa Bonnier, Santu Saha, Adam Austin, Biplab K Saha
A middle-aged man in his 50s, active smoker, presented to the pulmonary office for lung cancer evaluation. On a low-dose computed tomography for lung cancer screening, he was found to have an 8 mm endobronchial lesion in the right main stem bronchus. A PET-CT revealed no endobronchial lesion, but incidentally, fluorodeoxyglucose (FDG) avidity was present in the right hilar (SUV 13.2) and paratracheal lymph nodes (LNs). He underwent bronchoscopy and EBUS-TBNA of station 7 and 10 R LNs. The fine needle aspiration (FNA) revealed necrotizing epithelioid granuloma...
2024: Prague Medical Report
https://read.qxmd.com/read/38372128/a-real-world-study-of-quality-of-life-following-treatment-with-xylometazoline-hydrochloride-in-individuals-with-common-cold
#8
JOURNAL ARTICLE
Martina Hagen, Kim Clark, Pranab Kalita, Gessica Serra, Edwin Sanchez, Gabor Varbiro, Mathieu M Albasser
BACKGROUND: The common cold is a frequent, acute, and mild upper respiratory human disease. Nasal congestion has been considered the most bothersome symptom in the common cold, impacting quality of life (QoL). Topical decongestants containing steroids benefit QoL in allergic rhinitis, but no published research has assessed the impact of topical decongestants on QoL in the common cold. OBJECTIVE: To evaluate the effects of xylometazoline hydrochloride 0.1% (Otrivin, GSK Consumer Healthcare SARL, Switzerland) for up to 7 days on QoL in participants with nasal congestion associated with the common cold...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38340522/levels-of-procoagulant-factors-and-peak-thrombin-generation-in-relation-to-dementia-risk-in-older-adults-the-cardiovascular-health-study
#9
JOURNAL ARTICLE
Laura B Harrington, Alexa N Ehlert, Evan L Thacker, Nancy S Jenny, Oscar Lopez, Mary Cushman, Nels C Olson, Annette Fitzpatrick, Kenneth J Mukamal, Majken K Jensen
INTRODUCTION: Markers of hemostasis such as procoagulant factors and peak thrombin generation are associated with cardiovascular outcomes, but their associations with dementia risk are unclear. We aimed to evaluate prospective associations of selected procoagulant factors and peak thrombin generation with dementia risk. METHODS: We measured levels of 7 hemostatic factors (fibrinogen, factor VII coagulant activity [FVIIc], activated factor VII [FVIIa], factor VIIa-antithrombin [FVIIa-AT], factor XI antigen [FXI], peak thrombin generation, and platelet count) among participants in the Cardiovascular Health Study, a cohort of older adults free of dementia in 1992/1993 (n = 3185)...
February 4, 2024: Thrombosis Research
https://read.qxmd.com/read/38335474/effect-of-evobrutinib-on-slowly-expanding-lesion-volume-in-relapsing-multiple-sclerosis-a-post-hoc-analysis-of-a-phase-2-trial
#10
RANDOMIZED CONTROLLED TRIAL
Douglas L Arnold, Colm Elliott, Emily C Martin, Yann Hyvert, Davorka Tomic, Xavier Montalban
BACKGROUND AND OBJECTIVES: Chronic active lesions (CALs) are demyelinated multiple sclerosis (MS) lesions with ongoing microglia/macrophage activity, resulting in irreversible neuronal damage and axonal loss. Evobrutinib is a highly selective, covalent, CNS-penetrant, Bruton tyrosine kinase inhibitor. This post hoc analysis evaluated the effect of evobrutinib on slowly expanding lesion (SEL) volume, an MRI marker of CALs, assessed baseline-week 48 in a phase 2, double-blind, randomized trial (NCT02975349) in relapsing MS (RMS)...
March 12, 2024: Neurology
https://read.qxmd.com/read/38316221/evaluation-of-the-efficacy-and-safety-of-a-herbal-formulation-for-rheumatoid-arthritis-a-non-inferiority-randomized-controlled-trial
#11
JOURNAL ARTICLE
Ansari Umme Ammara Maqbool Ahmad, Qamar Uddin, Nazim Husain, Tasleem Ahmad, Syeda Hajra Fatima, Ahmed Minhajuddin
ETHNOPHARMACOLOGICAL RELEVANCE: Rheumatoid arthritis (RA) is a diverse disease characterized by a variable, progressive course of articular and extra-articular symptoms that are linked with pain, disability, and mortality. The exact cause of rheumatoid arthritis is still being investigated, and there is no treatment for this debilitating, persistent, painful disease. Qurs-e-Mafasil, a herbal Unani preparation, is regarded as a potent treatment for Waja'al-Mafasil, a condition clinically similar to rheumatoid arthritis, but scientific evidence is scarce...
February 3, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38220374/energy-and-nutrient-intake-in-older-adults-with-healthy-aging-during-the-corona-virus-disease-19-pandemic-a-cohort-study
#12
JOURNAL ARTICLE
Marcelle Ferreira Saldanha, Rodrigo Ribeiro Dos Santos, Ann Kristine Jansen
BACKGROUND AND OBJECTIVE: Lockdown measures implemented amid the COVID-19 pandemic promoted changes in lifestyle, particularly engagement in physical activity/exercise and dietary intake. However, few studies are available investigating the healthy older population, particularly in developing countries. Therefore, the objective of this study was to assess the impact of the COVID-19 pandemic on energy and nutrient intake among older adults with successful aging and to evaluate changes in muscle mass, strength and physical performance...
February 2024: Clinical Nutrition ESPEN
https://read.qxmd.com/read/38174159/cs1-a-controlled-release-formulation-of-valproic-acid-for-the-treatment-of-patients-with-pulmonary-arterial-hypertension-rationale-and-design-of-a-phase-2-clinical-trial
#13
JOURNAL ARTICLE
Raymond L Benza, Philip B Adamson, Deepak L Bhatt, Fredrik Frick, Gunnar Olsson, Niklas Bergh, Björn Dahlöf
Although rare, pulmonary arterial hypertension (PAH) is associated with substantial morbidity and a median survival of approximately 7 years, even with treatment. Current medical therapies have a primarily vasodilatory effect and do not modify the underlying pathology of the disease. CS1 is a novel oral, controlled-release formulation of valproic acid, which exhibits a multi-targeted mode of action (pulmonary pressure reduction, reversal of vascular remodeling, anti-inflammatory, anti-fibrotic, and anti-thrombotic) and therefore potential for disease modification and right ventricular modeling in patients with PAH...
January 2024: Pulmonary Circulation
https://read.qxmd.com/read/38131428/the-performance-of-hepatitis-b-surface-antigen-quantification-as-a-noninvasive-biomarker-predicting-liver-injury-and-serum-hepatitis-b-virus-dna-level
#14
JOURNAL ARTICLE
Madina Abdullayeva, Muammer Çelik, Ziya Kuruüzüm
OBJECTIVES: Chronic hepatitis B (CHB) is still a major public health problem worldwide. Recently, evidence indicating that serum hepatitis B surface antigen (HBsAg) quantification can be used for monitorization of hepatitis B virus (HBV) infection has been increased. In this study, we evaluated HBsAg levels during the natural course of CHB and identified correlations between HBsAg, HBV DNA levels and liver histopathology. METHODS: From 6 August 2016 to 7 June 2017, naive patients, who are ≥18 years old, fulfilled the criteria for the diagnosis of CHB and had a liver biopsy within a year before or after admission, were included...
February 1, 2024: European Journal of Gastroenterology & Hepatology
https://read.qxmd.com/read/38131374/the-performance-of-hepatitis-b-surface-antigen-quantification-as-a-noninvasive-biomarker-predicting-liver-injury-and-serum-hepatitis-b-virus-dna-level
#15
JOURNAL ARTICLE
Madina Abdullayeva, Muammer Çelik, Ziya Kuruüzüm
OBJECTIVES: Chronic hepatitis B (CHB) is still a major public health problem worldwide. Recently, evidence indicating that serum hepatitis B surface antigen (HBsAg) quantification can be used for monitorization of hepatitis B virus (HBV) infection has been increased. In this study, we evaluated HBsAg levels during the natural course of CHB and identified correlations between HBsAg, HBV DNA levels and liver histopathology. METHODS: From 6 August 2016 to 7 June 2017, naive patients, who are ≥18 years old, fulfilled the criteria for the diagnosis of CHB and had a liver biopsy within a year before or after admission, were included...
December 11, 2023: European Journal of Gastroenterology & Hepatology
https://read.qxmd.com/read/38088554/transcriptional-profiling-of-human-peripheral-blood-mononuclear-cells-in-household-contacts-of-pulmonary-tuberculosis-patients-provides-insights-into-mechanisms-of-mycobacterium-tuberculosis-control-and-elimination
#16
JOURNAL ARTICLE
Xiao Qi, Qingluan Yang, Jianpeng Cai, Jing Wu, Yan Gao, Qiaoling Ruan, Lingyun Shao, Jun Liu, Xueshi Zhou, Wenhong Zhang, Ning Jiang, Sen Wang
Abstract Household contacts (HHCs) of patients with active tuberculosis (ATB) are at higher risk of Mycobacterium tuberculosis ( M. tuberculosis ) infection. However, the immune factors responsible for different defense responses in HHCs are unknown. Hence, we aimed to evaluate transcriptome signatures in human peripheral blood mononuclear cells (PBMCs) of HHCs to aid risk stratification. We recruited 112 HHCs of ATB patients and followed them for 6 years. Among the HHCs, only 2 developed ATB, while the remaining HHCs were classified into three groups: 1) HHC-1 group (n = 23): HHCs with consistently positive T-SPOT...
December 13, 2023: Emerging Microbes & Infections
https://read.qxmd.com/read/38086704/comparison-of-three-methods-of-tonometry-in-patients-with-inactive-thyroid-associated-orbitopathy
#17
JOURNAL ARTICLE
M Karhanová, J Kalitová, M Malušková, J Schovánek, J Zapletalová, P Mlčák, K Marešová
INTRODUCTION: Intraocular pressure (IOP) measurement in patients with thyroid-associated orbitopathy (TAO) can be difficult and misleading, particularly in patients with diplopia and eye deviation (esotropia or hypotropia). However, when measuring IOP, it is also necessary to pay sufficient attention to TAO patients without diplopia in primary gaze direction and without motility disorder that might not be readily apparent. PURPOSE: The aim of this study was to evaluate the accuracy of measurement of intraocular pressure (IOP) using three different types of tonometers: the rebound tonometer (iCARE), the Goldmann applanation tonometer (GAT) and the non-contact airpuff tonometer (NCT) in patients with inactive TAO...
2023: Ceská a Slovenská Oftalmologie
https://read.qxmd.com/read/38086057/the-mn-ride-pilot-feasibility-of-a-synchronous-remotely-delivered-aerobic-exercise-training-program-for-rural-dwelling-adults-with-subjective-cognitive-decline
#18
JOURNAL ARTICLE
Dereck L Salisbury, Wayne Warry, Joshua Fergen, Kirsten Cruikshank, Patricia D Soderlund, Kristen Jacklin
INTRODUCTION: Out of all the modifiable risk factors for Alzheimer's disease and related dementias (ADRD), physical inactivity is the strongest. Rural residents have an increased risk for dementia and face significant barriers to accessing ADRD information, caregiving support, and memory-related services, which contributes to substandard care. Rural communities have greater barriers to participating in physical activity, and in particular exercise, due to lack of social support, travel/weather problems, and lack of facilities/equipment...
December 2023: Rural and Remote Health
https://read.qxmd.com/read/38006372/erythrodermic-presentation-of-atopic-dermatitis-in-a-patient-with-secondary-adrenal-insufficiency-caused-by-oral-glucocorticosteroid-abuse
#19
JOURNAL ARTICLE
Alicja Mesjasz, Magdalena Trzeciak, Jowita Sroka-Tomaszewska, Anna Zaryczańska, Roman J Nowicki
Dear Editor, A 41-year-old man presented to the Department of Dermatology for the first time due to an exacerbation of atopic dermatitis (AD) in the form of erythroderma. The patient had a history of atopic diseases, with being AD active from infancy. On clinical examination, generalized erythematous skin lesions causing acute pruritus and accompanied by severe skin exfoliation and dryness were present. On closer examination, the patient had a collection of signs and symptoms characterizing Cushing syndrome that included a round and full face (''moon face''), supraclavicular fat pads, and proximal muscle atrophy...
November 2023: Acta Dermatovenerologica Croatica: ADC
https://read.qxmd.com/read/37982428/infliximab-for-medical-induction-of-remission-in-crohn-s-disease
#20
JOURNAL ARTICLE
Morris Gordon, Vassiliki Sinopoulou, Anthony K Akobeng, Shellie J Radford, Mohsen Ebrahim Abdelhamid Ali Eldragini, Ana-Maria Darie, Gordon William Moran
BACKGROUND: Infliximab is a monoclonal antibody that binds and neutralises tumour necrosis factor-alpha (TNF-α), which is present in high levels in the blood serum, mucosa and stool of people with Crohn's disease. OBJECTIVES: To evaluate the benefits and harms of infliximab alone or in combination with another agent for induction of remission in Crohn's disease compared to placebo or active medical therapies. SEARCH METHODS: On 31 August 2021 and 4 March 2023, we searched CENTRAL, MEDLINE, Embase, ClinicalTrials...
November 20, 2023: Cochrane Database of Systematic Reviews
keyword
keyword
59433
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.